#United States #New York #Dmitri Alden #Hepatic Adenoma #Liver Surgery

Dr. Dmitri Alden Highlights Hepatic Adenoma Management

Dr. Dmitri Alden, a renowned surgical oncologist based in New York City, recently shared his expertise at the International Symposium on Hepato-Biliary-Pancreatic Surgery held in Paris from June 4 to 6, 2026. With a special focus on liver, biliary, and pancreatic surgical procedures, Dr. Alden contributed significantly to the ongoing discourse on hepatic adenomas, a type of benign liver tumor that can pose complex challenges in treatment.

The symposium was a monumental event marking the 40th anniversary of the Hepatobiliary Companions, an organization founded by Professor Henri Bismuth, which aims to foster collaboration among surgeons trained at the Paul Brousse Hospital and associated programs. This particular gathering attracted over 100 surgeons from 25 different countries, all eager to exchange knowledge and discuss advancements in liver and pancreatic surgery.

In his presentation, Dr. Alden elaborated on the management strategies for hepatic adenomas, highlighting the challenging decisions involved in surveillance and surgical intervention. His insights stem from years of experience treating a wide array of liver conditions, enabling him to provide valuable guidance on how best to approach these cases. He emphasized the necessity for tailored treatment plans, considering the clinical characteristics of each patient and tumor.

Moreover, Dr. Alden participated as an expert discussant on the critical subject of patient selection for major vascular reconstruction during surgery for complex liver tumors. This aspect of liver surgery is particularly demanding, as it often requires addressing tumors that are located in proximity to major blood vessels. During the symposium, he contributed his clinical knowledge to a dedicated session aimed at optimizing patient selection for liver resections accompanied by vascular reconstruction.

The theme of this year’s anniversary symposium, “When Innovation Meets Tradition for Better Care,” reflects the field's dynamic nature, bridging established surgical practices with innovative technologies and techniques. Dr. Alden’s commitment to integrating new approaches into traditional methods aligns perfectly with this theme, showcasing the future of surgical oncology.

In his New York practice, located at Lenox Hill Hospital, Dr. Alden employs minimally invasive and robotic-assisted techniques for liver and pancreatic surgeries. His expertise encompasses the treatment of various conditions, including both benign and complex cancers. Recognized for his contributions to the field, he has been consistently named on New York Magazine’s Best Doctors list since 2015, affirming his status as a leader in surgical oncology.

Reflecting on his experience at the symposium, Dr. Alden expressed, “It was an honor to connect with fellow specialists from across the globe to discuss vital topics in liver surgery. The exchange of knowledge regarding hepatic adenoma management and strategies for managing complex vascular reconstructions is crucial to advancing patient care.”

Dr. Dmitri Alden remains dedicated to improving surgical outcomes for patients facing liver diseases through innovative techniques and personalized treatment plans. For more information about his work, visit his website.